Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Tamminga

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 5, 2008
Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophreniaDaniel E Casey, David G Daniel, Carol Tamminga, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 19, 2013
Fluoxetine epigenetically alters the CaMKIIα promoter in nucleus accumbens to regulate ΔFosB binding and antidepressant effectsA J Robison, Vincent Vialou, Hao-Sheng Sun, et al.
Schizophrenia Bulletin|July 13, 2021
A Diagnosis and Biotype Comparison Across the Psychosis Spectrum: Investigating Volume and Shape Amygdala-Hippocampal Differences from the B-SNIP StudySynthia Guimond, Feng Gu, Holly Shannon, et al.
Journal of Neuroscience Methods|March 15, 2011
A framework on surface-based connectivity quantification for the human brainHao Huang, Jerry L Prince, Virendra Mishra, et al.
Translational Psychiatry|October 13, 2018
VEGFA GENE variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP studyPaulo Lizano, Olivia Lutz, George Ling, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 24, 2011
A novel role of the WNT-dishevelled-GSK3β signaling cascade in the mouse nucleus accumbens in a social defeat model of depressionMatthew B Wilkinson, Caroline Dias, Jane Magida, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|December 2, 2006
Risk factors for schizophrenia. Follow-up data from the Northern Finland 1966 Birth Cohort StudyMatti Isohanni, Jouko Miettunen, Pirjo Mäki, et al.
Research Square|January 23, 2024
Differentiating Biomarker Features and Familial Characteristics of B-SNIP Psychosis BiotypesDavid Parker, Rebekah Trotti, Jennifer McDowell, et al.
Psychiatry Research. Neuroimaging|March 8, 2020
Retinal layer abnormalities and their association with clinical and brain measures in psychotic disorders: A preliminary studyDeepthi Bannai, Paulo Lizano, Megan Kasetty, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2020
Molecular adaptations of the blood-brain barrier promote stress resilience vs. depressionKatarzyna A Dudek, Laurence Dion-Albert, Manon Lebel, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 5, 2008
Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophreniaDaniel E Casey, David G Daniel, Carol Tamminga, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 19, 2013
Fluoxetine epigenetically alters the CaMKIIα promoter in nucleus accumbens to regulate ΔFosB binding and antidepressant effectsA J Robison, Vincent Vialou, Hao-Sheng Sun, et al.
Schizophrenia Bulletin|July 13, 2021
A Diagnosis and Biotype Comparison Across the Psychosis Spectrum: Investigating Volume and Shape Amygdala-Hippocampal Differences from the B-SNIP StudySynthia Guimond, Feng Gu, Holly Shannon, et al.
Journal of Neuroscience Methods|March 15, 2011
A framework on surface-based connectivity quantification for the human brainHao Huang, Jerry L Prince, Virendra Mishra, et al.
Translational Psychiatry|October 13, 2018
VEGFA GENE variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP studyPaulo Lizano, Olivia Lutz, George Ling, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 24, 2011
A novel role of the WNT-dishevelled-GSK3β signaling cascade in the mouse nucleus accumbens in a social defeat model of depressionMatthew B Wilkinson, Caroline Dias, Jane Magida, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|December 2, 2006
Risk factors for schizophrenia. Follow-up data from the Northern Finland 1966 Birth Cohort StudyMatti Isohanni, Jouko Miettunen, Pirjo Mäki, et al.
Research Square|January 23, 2024
Differentiating Biomarker Features and Familial Characteristics of B-SNIP Psychosis BiotypesDavid Parker, Rebekah Trotti, Jennifer McDowell, et al.
Psychiatry Research. Neuroimaging|March 8, 2020
Retinal layer abnormalities and their association with clinical and brain measures in psychotic disorders: A preliminary studyDeepthi Bannai, Paulo Lizano, Megan Kasetty, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2020
Molecular adaptations of the blood-brain barrier promote stress resilience vs. depressionKatarzyna A Dudek, Laurence Dion-Albert, Manon Lebel, et al.
Pageof 7